BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Feb 21, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Cytomegalovirus: Phase II started

Cell Medica began the open-label, U.K. Phase II CMV-ACE/ASPECT trial to compare a single infusion of CMV-specific memory T cells plus antiviral therapy consisting of twice-daily 5 mg/kg IV...

Read the full 124 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >